$BSTG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Biostage, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Biostage, Inc.. Get notifications about new insider transactions in Biostage, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 03 2015 | HART | Biostage, Inc. | GREEN DAVID | Director | Buy | P | 1.98 | 23,400 | 46,332 | 288,259 | 264.9 K to 288.3 K (+8.83 %) |
| Jun 03 2015 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Buy | P | 1.95 | 1,000 | 1,950 | 13,724 | 12.7 K to 13.7 K (+7.86 %) |
| Jun 03 2015 | HART | Biostage, Inc. | McNaughton Thomas | Interim CEO & CFO | Buy | P | 2.01 | 5,000 | 10,050 | 56,128 | 51.1 K to 56.1 K (+9.78 %) |
| Jun 03 2015 | HART | Biostage, Inc. | McNaughton Thomas | Interim CEO & CFO | Buy | P | 1.80 | 8,000 | 14,400 | 51,128 | 43.1 K to 51.1 K (+18.55 %) |
| Jun 03 2015 | HART | Biostage, Inc. | McNaughton Thomas | Interim CEO & CFO | Buy | P | 1.74 | 3,000 | 5,220 | 43,128 | 40.1 K to 43.1 K (+7.48 %) |
| Jun 02 2015 | HART | Biostage, Inc. | GREEN DAVID | Director | Buy | P | 1.81 | 26,600 | 48,146 | 264,859 | 238.3 K to 264.9 K (+11.16 %) |
| Jun 02 2015 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Buy | P | 1.67 | 10,000 | 16,700 | 12,724 | 2.7 K to 12.7 K (+367.11 %) |
| Jun 02 2015 | HART | Biostage, Inc. | McNaughton Thomas | Interim CEO & CFO | Buy | P | 1.91 | 5,000 | 9,550 | 40,128 | 35.1 K to 40.1 K (+14.23 %) |
| Jun 02 2015 | HART | Biostage, Inc. | La Francesca Saverio | Chief Medical Offic ... | Buy | P | 1.85 | 5,000 | 9,250 | 11,714 | 6.7 K to 11.7 K (+74.47 %) |
| Jun 01 2015 | HART | Biostage, Inc. | McNaughton Thomas | Interim CEO and CFO | Option Exercise | A | 1.84 | 85,000 | 156,400 | 85,000 | |
| Jun 01 2015 | HART | Biostage, Inc. | Robinson Thomas H | Director | Option Exercise | A | 1.84 | 25,000 | 46,000 | 25,000 | |
| Jun 01 2015 | HART | Biostage, Inc. | La Francesca Saverio | Chief Medical Offic ... | Option Exercise | A | 1.84 | 40,000 | 73,600 | 40,000 | |
| Jun 01 2015 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Option Exercise | A | 1.84 | 25,000 | 46,000 | 25,000 | |
| Jun 01 2015 | HART | Biostage, Inc. | Canepa John J | Director | Option Exercise | A | 1.84 | 25,000 | 46,000 | 25,000 | |
| Jun 01 2015 | HART | Biostage, Inc. | McGorry James Joseph | Director | Option Exercise | A | 1.84 | 25,000 | 46,000 | 25,000 | |
| Jun 01 2015 | HART | Biostage, Inc. | GREEN DAVID | Director | Option Exercise | A | 1.84 | 25,000 | 46,000 | 25,000 | |
| Apr 02 2015 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Option Exercise | M | 4.75 | 139 | 660 | 0 | |
| Apr 02 2015 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Buy | M | 4.75 | 139 | 660 | 2,724 | 2.6 K to 2.7 K (+5.38 %) |
| Feb 19 2015 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Buy | P | 1.75 | 50,000 | 87,500 | 388,259 | 338.3 K to 388.3 K (+14.78 %) |
| Feb 13 2015 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Buy | P | 2.91 | 3,500 | 10,185 | 35,128 | 31.6 K to 35.1 K (+11.07 %) |
| Feb 13 2015 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Buy | P | 2.59 | 10,500 | 27,195 | 31,628 | 21.1 K to 31.6 K (+49.70 %) |
| Mar 20 2014 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Option Exercise | M | 8.20 | 12,261 | 100,540 | 0 | |
| Mar 20 2014 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Payment of Exercise | F | 10.69 | 9,404 | 100,529 | 338,259 | 347.7 K to 338.3 K (-2.70 %) |
| Mar 20 2014 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Buy | M | 8.20 | 12,261 | 100,540 | 347,663 | 335.4 K to 347.7 K (+3.66 %) |
| Jan 09 2014 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Payment of Exercise | F | 4.75 | 1,478 | 7,021 | 380,365 | 381.8 K to 380.4 K (-0.39 %) |
| Nov 18 2013 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Option Exercise | A | 4.29 | 72,563 | 311,295 | 72,563 | |
| Nov 18 2013 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Option Exercise | A | 4.29 | 145,126 | 622,591 | 145,126 | |
| Nov 18 2013 | HART | Biostage, Inc. | McGorry James Joseph | Director | Option Exercise | A | 4.29 | 25,000 | 107,250 | 25,000 | |
| Nov 18 2013 | HART | Biostage, Inc. | Robinson Thomas H | Director | Option Exercise | A | 4.29 | 25,000 | 107,250 | 25,000 | |
| Nov 18 2013 | HART | Biostage, Inc. | Canepa John J | Director | Option Exercise | A | 4.29 | 25,000 | 107,250 | 25,000 | |
| Nov 18 2013 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Option Exercise | A | 4.29 | 25,000 | 107,250 | 25,000 | |
| Nov 18 2013 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Option Exercise | A | 4.29 | 290,251 | 1,245,177 | 290,251 | |
| Nov 18 2013 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Option Exercise | A | 4.29 | 580,502 | 2,490,354 | 580,502 | |
| Nov 07 2013 | HART | Biostage, Inc. | GRAZIANO CHANE | 10% Owner | Gift | G | 0.00 | 100,000 | 0 | 676,287 | 776.3 K to 676.3 K (-12.88 %) |
| Nov 05 2013 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Option Exercise | J | 5.22 | 2,061 | 10,758 | 2,061 | |
| Nov 05 2013 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Option Exercise | J | 3.67 | 4,383 | 16,086 | 4,383 | |
| Nov 05 2013 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Option Exercise | J | 5.79 | 2,769 | 16,033 | 2,769 | |
| Nov 05 2013 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Option Exercise | J | 3.27 | 11,108 | 36,323 | 11,108 | |
| Nov 05 2013 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Option Exercise | J | 2.90 | 5,544 | 16,078 | 5,544 | |
| Nov 05 2013 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Buy | J | 0.00 | 4,396 | 0 | 21,128 | 16.7 K to 21.1 K (+26.27 %) |
| Nov 05 2013 | HART | Biostage, Inc. | McNaughton Thomas | Chief Financial Off ... | Buy | J | 0.00 | 16,732 | 0 | 16,732 | 0 to 16.7 K |
| Nov 05 2013 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Option Exercise | J | 5.22 | 4,434 | 23,145 | 4,434 | |
| Nov 05 2013 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Option Exercise | J | 3.67 | 9,424 | 34,586 | 9,424 | |
| Nov 05 2013 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Option Exercise | J | 5.79 | 5,954 | 34,474 | 5,954 | |
| Nov 05 2013 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Option Exercise | J | 3.27 | 22,217 | 72,650 | 22,217 | |
| Nov 05 2013 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Option Exercise | J | 2.05 | 4,173 | 8,555 | 4,173 | |
| Nov 05 2013 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Option Exercise | J | 5.72 | 11,100 | 63,492 | 11,100 | |
| Nov 05 2013 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Option Exercise | J | 8.20 | 12,261 | 100,540 | 12,261 | |
| Nov 05 2013 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Buy | J | 0.00 | 9,317 | 0 | 381,843 | 372.5 K to 381.8 K (+2.50 %) |
| Nov 05 2013 | HART | Biostage, Inc. | GREEN DAVID | Chief Executive Off ... | Buy | J | 0.00 | 372,526 | 0 | 372,526 | 0 to 372.5 K |
| Nov 05 2013 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Option Exercise | J | 5.22 | 631 | 3,294 | 631 | |
| Nov 05 2013 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Option Exercise | J | 3.67 | 893 | 3,277 | 893 | |
| Nov 05 2013 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Option Exercise | J | 5.79 | 997 | 5,773 | 997 | |
| Nov 05 2013 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Option Exercise | J | 3.71 | 950 | 3,525 | 950 | |
| Nov 05 2013 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Option Exercise | J | 3.27 | 999 | 3,267 | 999 | |
| Nov 05 2013 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Option Exercise | J | 4.89 | 277 | 1,355 | 277 | |
| Nov 05 2013 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Option Exercise | J | 5.31 | 279 | 1,481 | 279 | |
| Nov 05 2013 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Option Exercise | J | 3.08 | 1,109 | 3,416 | 1,109 | |
| Nov 05 2013 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Option Exercise | J | 4.75 | 139 | 660 | 139 | |
| Nov 05 2013 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Option Exercise | J | 4.31 | 277 | 1,194 | 277 | |
| Nov 05 2013 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Buy | J | 0.00 | 635 | 0 | 2,585 | 2 K to 2.6 K (+32.56 %) |
| Nov 05 2013 | HART | Biostage, Inc. | KENNEDY JOHN F | Director | Buy | J | 0.00 | 1,950 | 0 | 1,950 | 0 to 2 K |
| Nov 05 2013 | HART | Biostage, Inc. | HARVARD BIOSCIENCE INC | 10% Owner | Sell | J | 0.00 | 8,000,000 | 0 | 0 | 8 M to 0 (-100.00 %) |